Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDO ACE Trial
2007-005455-42Phase 4Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of budesonide and triamcinolone in Crohn's disease, sponsored by University Medical Center Utrecht. Primary endpoint: Recurrence of stenosis and/or need for surgical intervention. Started Sep 2008; status: terminated.
02
Drugs
budesonidetriamcinolone
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2007-005455-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005455-42.